Bionomics Quote - BNO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.01

Bid

0.011

Offer

0.01

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

0.01

Open

Last Trade

Last Trade Time

Average Volume (3m)

0.00

Financial Volume

VWAP

Australia's Bionomics Ltd. Files for IPO With U.S. SEC

By Stephen Nakrosis Biopharmaceutical company Bionomics Ltd. filed for an initial public offering with the U.S. Securities and Exchange Commission on Monday. The company's shares currently...

Recapitalisation Led by Sophisticated Life Sciences Investor - Apeiron Investment Group Ltd

Approximately A$20-A$22 million1 total funding to progress BNC210 development for the treatment of PTSD and other anxiety and stress-related disorders (subject to shareholder and FIRB approvals;...

Bionomics and MSD Scientists Publish Preclinical Findings for BNC375 in Peer-Reviewed Journal

Bionomics Limited (ASX: BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company, today announced that a paper describing the pharmacology of BNC375, a novel positive allosteric...

Sale of Bionomics’ French Subsidiaries to Domain Therapeutics

Bionomics Limited (ASX:BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company leveraging proprietary platform technologies to discover and develop a deep pipeline of novel drug...

Bionomics Announces Fast Track Designation Granted by U.S. FDA to BNC210 Development Program for the Treatment of PTSD

Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical stage biopharmaceutical company discovering and developing a pipeline of novel drug candidates targeting ion channels, announced...

Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder Trial Shows the Potential for Significant Patien...

Additional work undertaken on a drug exposure-response analysis shows a statistically significant response of BNC210 in treatment of PTSD symptoms, as measured by CAPS-5 at 12 weeks...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	-0.105	-91.3043478261	0.115	0.12	0.009	1196612	0.03490977	DE
260	-0.07	-87.5	0.08	0.485	0.009	1069330	0.0988671	DE

BNO - Frequently Asked Questions (FAQ)

What is the current Bionomics share price?

The current share price of Bionomics is AUD 0.01

What is the 1 year trading range for Bionomics share price?

Bionomics has traded in the range of AUD 0.00 to AUD 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WHKOWhiteHawk Limited	AUD 0.002 (100.00%)	462.22k
3DPPointerra Limited	AUD 0.072 (46.94%)	32.83M
AVMOAdvance Metals Ltd	AUD 0.02 (42.86%)	466.02k
SMNOAStructural Monitor	AUD 0.15 (36.36%)	269.55k
L1MOLightning Minerals Ltd	AUD 0.015 (36.36%)	118.6k
BPHOCommon Stock	AUD 0.001 (-50.00%)	28.01M
MMROMEC Resources Ltd	AUD 0.001 (-50.00%)	15.33M
NCCONAOS Emerging Opportunities Company Limited	AUD 0.003 (-40.00%)	829
MMRMEC Resources Ltd	AUD 0.003 (-40.00%)	5.57M
ACWOCActinogen Medical Limited	AUD 0.008 (-38.46%)	2.25M
1TTThrive Tribe Technologies Ltd	AUD 0.004 (14.29%)	63.16M
SGRStar Entertainment Group Limited	AUD 0.1225 (-12.50%)	59.15M
OVTOvanti Ltd	AUD 0.02 (-9.09%)	33.75M
3DPPointerra Limited	AUD 0.072 (46.94%)	32.83M
MRQMRG Metals Ltd	AUD 0.004 (0.00%)	30.02M